Silk Road Medical, Inc
SILK
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 17.53% | 23.04% | 27.77% | 33.98% | 42.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.53% | 23.04% | 27.77% | 33.98% | 42.67% |
| Cost of Revenue | 7.46% | 18.36% | 32.14% | 42.28% | 48.28% |
| Gross Profit | 21.47% | 24.84% | 26.12% | 30.93% | 40.59% |
| SG&A Expenses | 21.68% | 23.23% | 24.68% | 24.29% | 21.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.51% | 19.18% | 24.00% | 26.18% | 25.80% |
| Operating Income | -13.36% | -8.18% | -13.97% | -7.66% | 7.69% |
| Income Before Tax | -6.90% | 2.53% | -1.31% | 3.07% | 12.84% |
| Income Tax Expenses | 48.28% | 48.28% | 48.28% | 45.00% | 45.00% |
| Earnings from Continuing Operations | -6.92% | 2.50% | -1.33% | 3.05% | 12.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.92% | 2.50% | -1.33% | 3.05% | 12.82% |
| EBIT | -13.36% | -8.18% | -13.97% | -7.66% | 7.69% |
| EBITDA | -13.98% | -8.11% | -13.43% | -6.12% | 9.88% |
| EPS Basic | -2.74% | 8.24% | 6.80% | 11.55% | 19.14% |
| Normalized Basic EPS | -2.69% | 7.86% | 6.42% | 11.19% | 18.83% |
| EPS Diluted | -2.74% | 8.24% | 7.03% | 11.76% | 19.32% |
| Normalized Diluted EPS | -2.69% | 7.86% | 6.42% | 11.19% | 18.83% |
| Average Basic Shares Outstanding | 4.38% | 6.38% | 8.48% | 9.53% | 7.42% |
| Average Diluted Shares Outstanding | 4.38% | 6.38% | 8.48% | 9.53% | 7.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
